These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31440989)

  • 21. The artificial pancreas: how sweet engineering will solve bitter problems.
    Klonoff DC
    J Diabetes Sci Technol; 2007 Jan; 1(1):72-81. PubMed ID: 19888383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DIY artificial pancreas: A narrative of the first patient and the physicians' experiences from India.
    Kesavadev J; Saboo B; Kar P; Sethi J
    Diabetes Metab Syndr; 2021; 15(2):615-620. PubMed ID: 33725629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. History and Perspective on DIY Closed Looping.
    Lewis D
    J Diabetes Sci Technol; 2019 Jul; 13(4):790-793. PubMed ID: 30348013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Artificial Pancreas and Type 1 Diabetes.
    Nwokolo M; Hovorka R
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1614-1623. PubMed ID: 36734145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do-It-Yourself Artificial Pancreas System and the OpenAPS Movement.
    Lewis DM
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):203-213. PubMed ID: 31980119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Closed-loop systems - Update 2020].
    Melmer A; Tripyla A; Herzig D; Laimer M; Stettler C; Bally L
    Ther Umsch; 2020 Sep; 77(7):312-318. PubMed ID: 32996429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development?
    Trevitt S; Simpson S; Wood A
    J Diabetes Sci Technol; 2016 May; 10(3):714-23. PubMed ID: 26589628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artificial Pancreas: Current Progress and Future Outlook in the Treatment of Type 1 Diabetes.
    Ramli R; Reddy M; Oliver N
    Drugs; 2019 Jul; 79(10):1089-1101. PubMed ID: 31190305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review.
    Farrington C
    Diabet Med; 2018 Apr; 35(4):436-449. PubMed ID: 29247547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.
    Anderson SM; Dassau E; Raghinaru D; Lum J; Brown SA; Pinsker JE; Church MM; Levy C; Lam D; Kudva YC; Buckingham B; Forlenza GP; Wadwa RP; Laffel L; Doyle FJ; DeVries JH; Renard E; Cobelli C; Boscari F; Del Favero S; Kovatchev BP
    Diabetes Technol Ther; 2019 Feb; 21(2):73-80. PubMed ID: 30649925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. User and Healthcare Professional Perspectives on Do-It-Yourself Artificial Pancreas Systems: A Need for Guidelines.
    Shepard JA; Breton M; Nimri R; Roberts JTF; Street T; Klonoff D; Barnard-Kelly K
    J Diabetes Sci Technol; 2022 Jan; 16(1):224-227. PubMed ID: 33000636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CREATE (Community deRivEd AutomaTEd insulin delivery) trial. Randomised parallel arm open label clinical trial comparing automated insulin delivery using a mobile controller (AnyDANA-loop) with an open-source algorithm with sensor augmented pump therapy in type 1 diabetes.
    Burnside M; Lewis D; Crocket H; Wilson R; Williman J; Jefferies C; Paul R; Wheeler BJ; de Bock M
    J Diabetes Metab Disord; 2020 Dec; 19(2):1615-1629. PubMed ID: 32837953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An overview of advancements in closed-loop artificial pancreas system.
    Dermawan D; Kenichi Purbayanto MA
    Heliyon; 2022 Nov; 8(11):e11648. PubMed ID: 36411933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes.
    Lewis DM; Hussain S
    Diabetes Ther; 2022 Sep; 13(9):1683-1699. PubMed ID: 35913655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving the Safety and Functionality of an Artificial Pancreas System for Use in Younger Children: Input from Parents and Physicians.
    Gildersleeve R; Riggs SL; Cherñavvsky DR; Breton MD; DeBoer MD
    Diabetes Technol Ther; 2017 Nov; 19(11):660-674. PubMed ID: 28854339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automated Insulin Delivery (AID) Systems: Use and Efficacy in Children and Adults with Type 1 Diabetes and Other Forms of Diabetes in Europe in Early 2023.
    Bassi M; Franzone D; Dufour F; Strati MF; Scalas M; Tantari G; Aloi C; Salina A; d'Annunzio G; Maghnie M; Minuto N
    Life (Basel); 2023 Mar; 13(3):. PubMed ID: 36983941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Hypoglycaemia-Hyperglycaemia Minimizer System in the Management of Type 1 Diabetes.
    Levy BL; McCann TW; Finan DA
    Eur Endocrinol; 2016 Mar; 12(1):18-23. PubMed ID: 29632582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of reinforcement learning algorithms to meet the challenges of an artificial pancreas.
    Bothe MK; Dickens L; Reichel K; Tellmann A; Ellger B; Westphal M; Faisal AA
    Expert Rev Med Devices; 2013 Sep; 10(5):661-73. PubMed ID: 23972072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioural implications of traditional treatment and closed-loop automated insulin delivery systems in Type 1 diabetes: applying a cognitive restraint theory framework.
    Kahkoska AR; Mayer-Davis EJ; Hood KK; Maahs DM; Burger KS
    Diabet Med; 2017 Nov; 34(11):1500-1507. PubMed ID: 28626906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Benefits and Limits of Technological Advances in Glucose Management Around Physical Activity in Patients Type 1 Diabetes.
    Tagougui S; Taleb N; Rabasa-Lhoret R
    Front Endocrinol (Lausanne); 2018; 9():818. PubMed ID: 30713524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.